Company

Pattern Bioscience Inc.

Austin diagnostics company whose single-cell platform identifies bacteria and tests antibiotic susceptibility within hours.

About

Founded in 2016 in Austin, US, Pattern Bioscience Inc. sells diagnostics to hospitals, laboratories and healthcare providers, mainly in North America and Europe. Its single-cell microbiology platform identifies bacteria and tests antimicrobial susceptibility within hours, supporting targeted antibiotic treatment. The company was founded by Nick Arab and Ross Johnson. Its Series C on December 28, 2022 raised USD 23.50 mn from investors including Illumina Ventures and Omnimed Capital, valuing the company at USD 86.41 mn.

4Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in